← Directory | States | Florida | Miami

NU LIFE INSTITUTE

Miami, Florida

Loading review totals...

in person

Map

Medical Director & Staff

Public profile data for NU LIFE INSTITUTE references Dr. Frank J. Welch and Dr. Frank J. Welch, M.D.** serves as the Medical Director. He advocates for slowing down the aging process through balanced hormone levels, diet, nutrition, and exercise in medical director or clinical leadership roles. ABOM certification is not currently confirmed in the directory dataset, so patients may want to verify obesity-medicine credentials directly. If staffing detail is important for your care plan, ask the clinic which licensed professionals supervise prescribing, follow-up, and dose titration.

Medical Director(s):

Dr. Frank J. Welch
Dr. Frank J. Welch, M.D.** serves as the Medical Director. He advocates for slowing down the aging process through balanced hormone levels, diet, nutrition, and exercise

GLP-1 Medications Offered

Common GLP-1 medications by generic and brand name, including compounded options.

Medication	Generic	Form	Primary Use	Clinic Availability
Ozempic	Semaglutide	Weekly injection	Type 2 Diabetes	Possible
Wegovy	Semaglutide	Weekly injection	Weight loss	Possible
Rybelsus	Semaglutide	Daily oral tablet	Type 2 Diabetes	Possible
Mounjaro	Tirzepatide (Dual GIP/GLP-1 agonist)	Weekly injection	Type 2 Diabetes	Possible
Zepbound	Tirzepatide (Dual GIP/GLP-1 agonist)	Weekly injection	Weight loss	Possible
Compounded Semaglutide	Semaglutide	Compounded formulation	Weight management / metabolic care	Not confirmed
Compounded Tirzepatide	Tirzepatide	Compounded formulation	Weight management / metabolic care	Not confirmed

Care & Access Snapshot

Quick operational snapshot to bridge medication availability and cost details.

Care Model

Consultation: in person

Insurance Concierge: No

Reported medications: 0 | Possible: 5

Medication Access Signals

Reported: No medications explicitly reported yet.

Possible: Ozempic, Wegovy, Rybelsus, Mounjaro

Priced Products Found: Semaglutide brand (Ozempic/Wegovy)

Pricing Snapshot

Pricing rows are mapped to likely medication names from clinic/source text. Benchmark columns show actual dollar averages for this product in city, state, and national datasets.

Medication	Monthly Membership	Out-of-Pocket Estimate	Total Cost	City Avg Total Cost	State Avg Total Cost	National Avg Total Cost
Semaglutide brand (Ozempic/Wegovy)	Not listed	Not listed	Not listed	$552	$304	$311

No numeric pricing rows available yet to model dose-based titration pricing.

Clinic Pricing Submission

Clinic representatives can add current pricing by medication and dose. Entries are saved in-browser for quick updates and review.

Total Cost of Care (TCOC)

Monthly Average

Not listed

Annual Expected Cost

Not listed

GLP-1 treatment is often long-term. Annual cost assumes 12 months at the clinic's monthly average total cost.

Simple GLP-1 Weight Loss Calculator

Starting Weight (lb)

240 lb

Medication Type

Monthly cost: -

Estimated Weight Loss: -

Estimated Weight at Outcome: -

Estimated Time to Outcome: -

Estimated Total Cost to Outcome: -

12-Month Projection: -

Evidence Basis: -

Estimated by GLP-1 Type

Semaglutide

Monthly Cost: -

Estimated Weight Loss: -

Estimated Outcome Weight: -

Estimated Time: -

Estimated Total Cost: -

Evidence: -

Tirzepatide

Monthly Cost: -

Estimated Weight Loss: -

Estimated Outcome Weight: -

Estimated Time: -

Estimated Total Cost: -

Evidence: -

Estimates use study-average percent weight loss by medication type and your clinic's listed monthly cost for that medication row. Compounded entries are modeled using published outcomes of the corresponding molecule and are not FDA-reviewed compounded-product efficacy claims.

Claim Your Profile

Following the instructions to Claim this profile to edit the listings or upgrade.

3 options: Claimed (Free), Advanced, Elite.

Request an Appointment

Paid memberships can accept appointment requests directly from the profile.

Loading appointment tools...